Region Halland

Research site

Sweden Lasarettsvagen 1, 302 33 Halmstad, Sweden

9 trials recruiting
Chronic lymphocytic leukaemia · End stage renal disease · Obesity
Adults and children

About Specializations

Region Halland in Halmstad, Sweden specialises in clinical trials of conditions such as Chronic lymphocytic leukaemia, End stage renal disease, Obesity, Mantle cell lymphoma, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Lasarettsvagen 1302 33 HalmstadSweden

Open in maps ↗

Recruiting now: 9 trials
Conditions studied: 24

More sites in Halmstad Sweden

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

19 clinical trials

Cardiovascular disorder+2

Recruiting

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:BI 690517
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Therapy cessation

Recruiting

Study of the effects of stopping elranatamab and teclistamab treatment in patients with multiple myeloma who have had a significant response to therapy.

Registered drugNo placebo

Study of the effects of stopping elranatamab and teclistamab treatment in patients with multiple myeloma who have had a significant response to therapy.

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Elranatamab
Sponsor:Vaestra Goetalandsregionen

Contact Research Centre

Cervix carcinoma

Recruiting

Study on HPV Vaccine and Screening to Reduce HPV Infection and Cervical Cancer in Swedish Women Aged 23-25

Registered drugNo placebo

Study on HPV Vaccine and Screening to Reduce HPV Infection and Cervical Cancer in Swedish Women Aged 23-25

Registered drugNo placebo

Sweden

Participants:18–64 years · Healthy volunteers
Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
Sponsor:Region Stockholm

Contact Research Centre

Measles

Recruiting

Study on Immunity to Measles and Chickenpox in Children with Cancer Using Measles, Mumps, Rubella, and Varicella Vaccines

Registered drugNo placebo

Study on Immunity to Measles and Chickenpox in Children with Cancer Using Measles, Mumps, Rubella, and Varicella Vaccines

Registered drugNo placebo

Sweden

Participants:0–17 years · Healthy volunteers
Substances:Measles virus edmonston-schwarz strain (live, attenuated) produced in chick embryo cells
Sponsor:Vaestra Goetalandsregionen

Contact Research Centre

Chronic lymphocytic leukaemia+1

Recruiting

Study on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo

Study on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Obinutuzumab
Sponsor:University Of Cologne

Contact Research Centre

End stage renal disease

Recruiting

Study on XyloCore and Drug Combination for Patients with End-Stage Kidney Disease Undergoing Peritoneal Dialysis

Registered drugNo placebo

Study on XyloCore and Drug Combination for Patients with End-Stage Kidney Disease Undergoing Peritoneal Dialysis

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Glucose Monohydrate
Sponsor:Iperboreal Pharma S.r.l.

Contact Research Centre

Induced labour+1

Recruiting

Study on Misoprostol for Inducing Labor in Pregnant Women: Comparing Outpatient and Inpatient Settings

Registered drugNo placebo

Study on Misoprostol for Inducing Labor in Pregnant Women: Comparing Outpatient and Inpatient Settings

Registered drugNo placebo

Sweden

Participants:18–64 years
Substances:Misoprostol
Sponsor:University Of Gothenburg

Contact Research Centre

Atrial fibrillation+2

Recruiting

Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

Registered drugNo placebo

Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Karolinska University Hospital

Contact Research Centre

Urinary tract infection+1

Recruiting

Study of Pivmecillinam and Amoxicillin/Clavulanic Acid for Treating Urinary Tract Infections in Patients with Multidrug-Resistant Bacteria

Registered drugNo placebo

Study of Pivmecillinam and Amoxicillin/Clavulanic Acid for Treating Urinary Tract Infections in Patients with Multidrug-Resistant Bacteria

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Amoxicillin
Sponsor:Region Skane

Contact Research Centre

Procedural pain

Not yet recruiting

Study on Magnesium Sulfate for Reducing Postoperative Pain in Women After Cesarean Section

Registered drugNo placebo

Study on Magnesium Sulfate for Reducing Postoperative Pain in Women After Cesarean Section

Registered drugNo placebo

Sweden

Participants:18–64 years
Substances:Magnesium Sulfate
Sponsor:Region Halland

Contact Research Centre

Diffuse large B-cell lymphoma refractory

Not yet recruiting

Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

Registered drugNo placebo

Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

Registered drugNo placebo

Sweden

Participants:65+ years
Substances:Cyclophosphamide
Sponsor:Region Skane

Contact Research Centre

Obesity

Not recruiting

Study on Maintaining Weight Loss in Teens with Obesity Using Semaglutide

Registered drugNo placebo

Study on Maintaining Weight Loss in Teens with Obesity Using Semaglutide

Registered drugNo placebo

Sweden

Participants:0–17 years
Substances:Semaglutide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites